Correlation Between SAB Biotherapeutics and Quantum Si

Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Quantum Si at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Quantum Si into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SAB Biotherapeutics and Quantum Si incorporated, you can compare the effects of market volatilities on SAB Biotherapeutics and Quantum Si and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Quantum Si. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Quantum Si.

Diversification Opportunities for SAB Biotherapeutics and Quantum Si

0.79

Correlation Coefficient

SAB Biotherapeutics  Quantum Si

Poor diversification

The 3 months correlation between SAB and Quantum is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Quantum Si incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quantum Si incorporated and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Quantum Si. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quantum Si incorporated has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Quantum Si go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and Quantum Si

Given the investment horizon of 90 days SAB Biotherapeutics is expected to under-perform the Quantum Si. But the stock apears to be less risky and, when comparing its historical volatility, SAB Biotherapeutics is 1.75 times less risky than Quantum Si. The stock trades about 0.0 of its potential returns per unit of risk. The Quantum Si incorporated is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  60.00  in Quantum Si incorporated on March 31, 2024 and sell it today you would lose (47.00) from holding Quantum Si incorporated or give up 78.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	93.35%
Values	Daily Returns

SAB Biotherapeutics  vs.  Quantum Si incorporated

SAB Biotherapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SAB Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in July 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Quantum Si incorporated

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Quantum Si incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in July 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with SAB Biotherapeutics and Quantum Si

The main advantage of trading using opposite SAB Biotherapeutics and Quantum Si positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Quantum Si can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quantum Si will offset losses from the drop in Quantum Si's long position.

The idea behind SAB Biotherapeutics and Quantum Si incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.